Galmika 250mg Injection
Marketer
Galpha Laboratories Ltd
Salt Composition
Amikacin (250mg)
Overview Galmika 250mg Injection
Cefazolin 250mg Injection is a broad-spectrum antibiotic combating diverse bacterial infections. These encompass urinary tract, bone, joint, lung (such as pneumonia), brain, and bloodstream infections, among others. Prophylactic use is also indicated in hospitalized individuals to avert infections. Cefazolin 250mg Injection's mechanism involves bacterial growth inhibition. Administration, via intravenous infusion or intramuscular injection, requires a healthcare professional's oversight and should never be self-administered. Adherence to the prescribed dosage schedule, with evenly spaced intervals, is crucial. Completing the entire course is essential; premature cessation risks relapse or infection exacerbation. Typical adverse effects include injection site reactions and elevated blood urea nitrogen. Persistent side effects or treatment inefficacy warrant immediate medical consultation. High doses may rarely cause vertigo, nephrotoxicity, and ototoxicity. Strict adherence to physician instructions is paramount, including potential monitoring via renal function, audiometric, and urinalysis testing. This antibiotic is contraindicated during pregnancy. Disclose pregnancy, pregnancy planning, or breastfeeding to your physician.
Uses of Galmika 250mg Injection
Infections caused by bacteria
Major Benefits of Galmika 250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Galmika 250mg Injection:
- Increased blood urea
- Injection site reactions (pain, swelling, redness)
How to use Galmika 250mg Injection:
This medication will be administered by your healthcare provider; self-medication is strongly discouraged.
How Galmika 250mg Injection works:
Galmika 250mg Injection, an antibacterial medication, inhibits bacterial proliferation by disrupting the production of crucial proteins necessary for bacterial survival.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concomitant use of Galmika 250mg Injection and alcohol.
PregnancyCONSULT YOUR DOCTOR
Administering Galmika 250mg Injection during pregnancy is contraindicated due to established risks to the fetus. In exceptional, life-threatening circumstances, a physician might consider its use if the potential benefits outweigh the known hazards. Physician consultation is mandatory.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Galmika, 250mg, presents a low risk during lactation. Research in humans indicates minimal transfer of the drug into breast milk, posing no apparent danger to the infant.
DrivingUNSAFE
Administering Galmika 250mg Injection can induce drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if such effects manifest.
KidneyCAUTION
For individuals with kidney impairment, administration of Galmika 250mg Injection requires careful consideration. Dosage modification of Galmika 250mg Injection might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Galmika 250mg Injection in patients with liver impairment appears to present a low risk. Current evidence indicates dose modification may be unnecessary, however, physician consultation is recommended.
What if you forget to take Galmika 250mg Injection :
Omitting a scheduled dose of Galmika 250mg Injection warrants immediate physician consultation.
Facts to Know About Galmika 250mg Injection
| Label | Value |
|---|---|
| Chemical Category | Aminoglycoside antibiotics |
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
| Actions | Aminoglycoside antibiotics |
3,018 People bought this recently